With IPMN progression, tumor stemness increased continuously, and KRAS, ERBB3, RUNX1, and ELF3 are essential driver genes affecting tumor stemness. The gene discussed is RUNX1; the disease is pancreatic intraductal papillary-mucinous neoplasm.